ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 154 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,750 | +114.4% | 183 | +108.0% | 0.00% | – |
| Q2 2023 | $1,749 | +16.1% | 88 | 0.0% | 0.00% | – |
| Q1 2023 | $1,507 | -12.5% | 88 | 0.0% | 0.00% | – |
| Q4 2022 | $1,722 | +72.2% | 88 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 88 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | -90.0% | 88 | -62.7% | 0.00% | -100.0% |
| Q1 2021 | $10,000 | -88.6% | 236 | -85.2% | 0.00% | -90.9% |
| Q4 2020 | $88,000 | +125.6% | 1,600 | -5.9% | 0.02% | +100.0% |
| Q3 2020 | $39,000 | +85.7% | 1,700 | +13.3% | 0.01% | +37.5% |
| Q1 2020 | $21,000 | -38.2% | 1,500 | 0.0% | 0.01% | -33.3% |
| Q4 2019 | $34,000 | -2.9% | 1,500 | -50.0% | 0.01% | -7.7% |
| Q3 2019 | $35,000 | +133.3% | 3,000 | +200.0% | 0.01% | +116.7% |
| Q2 2019 | $15,000 | +114.3% | 1,000 | +100.0% | 0.01% | +100.0% |
| Q4 2018 | $7,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 16,812,491 | $234,534,000 | 10.10% |
| TANG CAPITAL MANAGEMENT LLC | 2,965,485 | $41,369,000 | 5.81% |
| Ghost Tree Capital, LLC | 650,000 | $9,068,000 | 2.40% |
| Boxer Capital, LLC | 1,466,051 | $20,451,000 | 1.39% |
| Vivo Capital, LLC | 860,648 | $12,006,000 | 1.09% |
| Samsara BioCapital, LLC | 128,197 | $1,788,000 | 1.03% |
| Cormorant Asset Management, LP | 1,568,550 | $21,881,000 | 1.02% |
| Perceptive Advisors | 2,189,010 | $30,537,000 | 0.80% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,677,367 | $23,399,000 | 0.74% |
| Eventide Asset Management | 1,415,000 | $19,739,000 | 0.64% |